A Retinoid/Butyric Acid Prodrug Overcomes Retinoic Acid Resistance in Leukemias by Induction of Apoptosis1
Grant 542/00-3 from Israel Science Foundation (to A.R. and A.N.); Marcus Center for Pharmaceutical and Medicinal Chemistry at Bar Ilan University (to A.N.); NIH CA85748 (to S.W.); Canadian Institute of Health Research (to W.H.M.); and a Translational Research Grant from the Leukemia and Lymphoma Society (to W.H.M.). W.H.M. is an Investigator of the CIHR and K.K.M. is a fellow of the Leukemia Research Fund of Canada. Z.D. is supported by the Max Stern Recruitment Fellowship.